Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion

Abstract

IntroductionDeregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGFβ) in breast cancer progression.MethodsCyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion.ResultsWe found TGFβ to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGFβ-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGFβ-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGFβ promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21.ConclusionsThus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGFβ-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.

TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway

“…Furthermore, our data confirmed that a significant reduction of CDK4, P70S6K, and Cyclin D1 with increased P53 in TRIM22 knockdown K562 cells (Figures C and D). CDK4, P70S6K, Cyclin D1, and P53 are pivotal regulators involved in cell cycle to affect tumor cell proliferation, and P53 is a well‐known anti‐oncogene (Skomedal et al, ; Jirawatnotai et al, ; Dai et al, ; Wang et al, ; Qiu et al, ). Above these results, TRIM22 deficiency inhibits cell proliferation via inducing cell cycle arrest by regulating cell cycle‐related proteins in CML cells.…”

c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway

“…In addition, c-Myb was found to bind to the Axin2 promoter directly, and thereby to induce Axin2 expression and enhance breast tumor progression. High expression of Cyclin D1 promotes local invasion and is associated with bone metastasis (41). Axin2 can fine-tune Wnt signaling and counteract excessive signaling as a Wnt feedback inhibitor, but, more importantly, Axin2 also acts as a chaperone for GSK3b and controls its subcellular location in human breast cancer.…”

Effect of Crocin on Cell Cycle Regulators in N-Nitroso-N-Methylurea-Induced Breast Cancer in Rats

“…Although p21 has been known as the inhibitor of CDKs, the coexpression of cyclin D1 and p21 protein is required for the initial steps of tumor development. The overexpression of cyclin D1 and p21 are often reported in human cancers and is correlated with a high tumor grade and poor prognosis (Dai et al, 2013).…”